[
  {
    "ts": null,
    "headline": "Why AbbVie's Stock Is A Strong Buy After Q1 2025 Results",
    "summary": "AbbVie had a strong Q1 performance in its oncology, neuroscience, and immunology franchises. Read why I continue to rate ABBV stock with a Strong Buy rating.",
    "url": "https://finnhub.io/api/news?id=84162b30566b031fd2f5778e89372d55a47095c8c4be23c7927690a903b8a620",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745797235,
      "headline": "Why AbbVie's Stock Is A Strong Buy After Q1 2025 Results",
      "id": 134110498,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1193052383/image_1193052383.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "AbbVie had a strong Q1 performance in its oncology, neuroscience, and immunology franchises. Read why I continue to rate ABBV stock with a Strong Buy rating.",
      "url": "https://finnhub.io/api/news?id=84162b30566b031fd2f5778e89372d55a47095c8c4be23c7927690a903b8a620"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie Inc. (ABBV): Among Billionaire Ken Fisher’s Healthcare Stock Picks with Massive Upside Potential",
    "summary": "We recently published a list of Billionaire Ken Fisher’s 10 Healthcare Stock Picks with Massive Upside Potential. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against other Billionaire Ken Fisher’s healthcare stock picks with massive upside potential. The healthcare industry, an essential component of global well-being and […]",
    "url": "https://finnhub.io/api/news?id=3608e1d2ccc983a9d376e92577b15f0c38e74af6dd6396f00508173e156e11b8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745780286,
      "headline": "AbbVie Inc. (ABBV): Among Billionaire Ken Fisher’s Healthcare Stock Picks with Massive Upside Potential",
      "id": 134115096,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "We recently published a list of Billionaire Ken Fisher’s 10 Healthcare Stock Picks with Massive Upside Potential. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against other Billionaire Ken Fisher’s healthcare stock picks with massive upside potential. The healthcare industry, an essential component of global well-being and […]",
      "url": "https://finnhub.io/api/news?id=3608e1d2ccc983a9d376e92577b15f0c38e74af6dd6396f00508173e156e11b8"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags",
    "summary": "AbbVie ( NYSE:ABBV ) First Quarter 2025 Results Key Financial Results Revenue: US$13.3b (up 8.4% from 1Q 2024). Net...",
    "url": "https://finnhub.io/api/news?id=f9f69a024391808e7e016115e70b93df4d241cbb0e3370c60e57c749dec2df15",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745759399,
      "headline": "AbbVie First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags",
      "id": 134115097,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "AbbVie ( NYSE:ABBV ) First Quarter 2025 Results Key Financial Results Revenue: US$13.3b (up 8.4% from 1Q 2024). Net...",
      "url": "https://finnhub.io/api/news?id=f9f69a024391808e7e016115e70b93df4d241cbb0e3370c60e57c749dec2df15"
    }
  }
]